Zhou Zhengrong

Dr. Zhou Zhengrong


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
PHPan Huang
Pan Huang
YZYan Zhou
Yan Zhou
WTWeihong Tang
Weihong Tang
CRCaifang Ren
Caifang Ren
AJAnqi Jiang
Anqi Jiang
AGAihua Gong
Aihua Gong

22 July 2024 in The FASEB Journal
Verified
Journal Article
Closed access
CRCaifang Ren
Caifang Ren
张爽张 爽
张 爽
YCYanyan Chen
Yanyan Chen
Kaiping DengKaiping Deng
Kaiping Deng
MKMeiqian Kuang
Meiqian Kuang
AGAihua Gong
Aihua Gong

8 December 2024 in Biology
Verified
Journal Article
Open access
PDF file
CRCaifang Ren
Caifang Ren
张爽张 爽
张 爽
JMJianyu Ma
Jianyu Ma
JHJunjie Huang
Junjie Huang
PHPan Huang
Pan Huang
AGAihua Gong
Aihua Gong
Polycystic ovary syndrome (PCOS) involves complex genetic, metabolic, endocrine, and environmental factors. This study explores the effects of nicotinamide mononucleotide (NMN) in a letrozole-induced PCOS mouse model, focusing on metabolic regulation. Letrozole-induced aromatase inhibition elevated androgen and reduced bile acid levels, linking liver dysfunction and gut imbalance to PCOS. Letrozole-treated mice exhibited disrupted estrous cycles, ovarian congestion, and elevated testosterone. NMN intervention alleviated hyperandrogenism, ovarian abnormalities, and bile acid decline but did not fully restore the estrous cycle or improve lipid profiles. Metabolomic analysis showed that NMN partially reversed bile acid and lipid metabolism disturbances. These findings highlight NMN’s protective role in reducing hyperandrogenism and ovarian cyst formation. However, effective PCOS treatment should target liver and gut metabolism, not just ovarian symptoms, to mitigate systemic effects. Bile acid dysregulation may play a key role in PCOS progression and warrants further investigation.

1 March 2020 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
PHPan Huang
Pan Huang
WTWeihong Tang
Weihong Tang
RSRong Shen
Rong Shen
XJXiaoli Ju
Xiaoli Ju
GSGenbao Shao
Genbao Shao
CRCaifang Ren
Caifang Ren
Stress-induced gastric ulcer is one of the common complications affecting patients after trauma, mainly leading to gastrointestinal bleeding and perforation, and severe cases may be life-threatening. However, the molecular mechanism of stress-induced gastric ulcer remains unclear. In the present study, RNA-sequencing was performed on gastric tissues of normal rats (C), stress-induced gastric ulcer rats (T0), and rats recovered from gastric ulcer for 3 days (T3), and bioinformatics analysis was performed to determine changes in gene expression and biological pathways. The protein–protein interaction (PPI) networks of differentially expressed genes (DEGs) were constructed by STRING and visualized by the Cytoscape software. The associated transcriptional factor (TFs)–gene regulatory network of the hub DEGs was also constructed. Pairwise comparisons obtained 103 (T0_C), 127 (T3_T0), and 13 (T3_C) DEGs, respectively. Gene ontology (GO) enrichment analysis indicated DEGs in T0_C and T3_T0 were significantly enriched in response to oxygen-containing compound, response to organic substance, and response to external stimulus. Pathway analysis suggested that DEGs were enriched in TNF signaling pathway, PPAR signaling pathway, apoptosis, and IL-17 signaling pathway. Seven hub genes (Fos, Jun, Nfkbia, Dusp1, Pim3, Junb, and Fosb) were obtained from the PPI networks of T0_C and T3_T0. Key TFs with close interactions, such as Fos, Jun, Nfkbia, Junb, Egr1, and Fosb, were screened This study used RNA-sequencing and bioinformatics analysis to screen out genes associated with gastric ulcer, which can help reveal the molecular mechanism of gastric ulcer development and restoration, and provide reference for the treatment of human gastric ulcers.

20 May 2026 in Biology
Verified
Journal Article
Open access
PDF file
JZJinyi Zhen
Jinyi Zhen
ZZZhou Zhengrong
Zhou Zhengrong
RZRuiqi Zhu
Ruiqi Zhu
MKMeiqian Kuang
Meiqian Kuang
PHPan Huang
Pan Huang
Irritable bowel syndrome (IBS) is a multifactorial functional intestinal disorder whose pathogenesis involves intestinal microbiota imbalance, mucosal barrier impairment, immune–inflammatory responses, and dysregulation of the gut–brain axis. Lactobacillus reuteri has been shown to modulate the gut microbiota, produce antimicrobial metabolites, strengthen the intestinal mucosal barrier, suppress inflammatory responses, and participate in gut–brain axis regulation, thereby potentially contributing to the maintenance of intestinal homeostasis and the alleviation of IBS-related symptoms. These findings indicate that L. reuteri holds potential therapeutic value in the prevention and treatment of IBS. However, the majority of supporting evidence derives from animal experiments, in vitro studies, or indirect sources, and its precise mechanisms of action and clinical efficacy warrant further investigation.